| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP &Chief Financial Officer
3 companies
Foletta Mark G is a Director at DexCom, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 1 buy and 25 sells.
Estimated insider holdings value: $4.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | AMN Amn Healthcare Services, Inc. | Director | Sell | 3,681 | $31.07 | $114,361.63 | -8.9% | - | - | |
| Jun 15, 2026 | DXCM Dexcom, Inc. | Director | Sell | 4,000 | $74.13 | $296,539.60 | -3.6% | - | - | |
| Aug 15, 2025 | DXCM Dexcom Inc | Director | Sell | 2,750 | $81.06 | $222,902.82 | -2.6% | -26.2% | - | |
| Jul 15, 2025 | DXCM Dexcom Inc | Director | Sell | 2,750 | $85.17 | $234,216.70 | -2.5% | -23.1% | - | |
| Jun 16, 2025 | DXCM Dexcom Inc | Director | Sell | 2,750 | $83.13 | $228,604.75 | -4.6% | -8.9% | -11.9% | |
| Jun 18, 2024 | DXCM Dexcom Inc | Director | Sell | 6,000 | $117.00 | $702,028.84 | -2.0% | -39.9% | -30.5% | |
| Feb 29, 2024 | AMN Amn Healthcare Services Inc | Director | Buy | 500 | $56.90 | $28,450.00 | +6.2% | -4.0% | -55.0% | |
| Apr 21, 2023 | AMN Amn Healthcare Services Inc | Director | Sale+OE | 1,458 | $88.78 | $129,441.24 | -15.3% | +25.8% | -35.9% | |
| Apr 11, 2023 | AMN Amn Healthcare Services Inc | Director | Sell | 6,042 | $84.35 | $509,638.20 | -26.0% | +31.7% | -30.1% | |
| Dec 1, 2021 | DXCM Dexcom Inc | Director | Sell | 500 | $562.83 | $281,415.78 | -0.5% | -25.5% | -13.9% |